
Camtek
Capital-equipment OEM: sells inspection/metrology tools (Eagle, Hawk, Golden Eye, MicroProf families) to memory makers and OSATs, with recurring service, spare parts, and software/upgrades attached to a growing installed base. Lumpy, order-driven hardware revenue with a smaller annuity tail.
Sources — 7 figures with citations
- Latest print: Q3 2026 (quarter ended 2026-09-30, released 2026-11-04)filed2026-11-12revenue $161.3 million; +28% YoY (from $126.0 million); +21% QoQ; guide: Q4 2026 approximately $180 million (about +40% YoY); FY2026 approximately $595 million; 2027 initial outlook above $800 million (about +35%)sec.gov — Recorded Nov 12 2026; figures as the source states them. The entry's analysis text predates this print unless dated otherwise.
- earnings, 2026-11-04filed2026-11-04Q3 2026: record revenue $161.3 million (+28% YoY from $126.0 million, +21% QoQ); GAAP gross margin 50.0% / non-GAAP 51.1%; GAAP operating income $39.8 million (24.7%) / non-GAAP $47.5 million (29.5%, a record margin); GAAP net income $42.8 million, diluted EPS $0.84; non-GAAP net income $50.3 million, diluted EPS $0.99; operating cash flow $71.1 million; cash, deposits and marketable securities $877.1 million (from $815.8 million);sec.gov — CONFIRMED; recorded Nov 12 2026; source dated 2026-11-04
- guidance, 2026-11-04filed2026-11-04Earnings call: more than $800 million of orders from the start of 2026 through the October investor event with momentum continuing; about 80% of Q3 revenue and about 80% of orders are advanced packaging, nearly all high-end AI; non-GAAP gross margin eased to 51.1% (from 51.4%) on parts and component costs with gradual improvement expected from Q1 2027; hybrid bonding remains low-level and is not expected to be a substantial contributor in 2027, with meaningful commercialization from 2028; China remains strong and 'a meaningful part' of the 2027 backlog;marketbeat.com — REPORTED; recorded Nov 12 2026; source dated 2026-11-04
- Watched signal: H2 FY26 revenue landing more than 30% above H1 (Q3 $160-161M pre-announced, Q4 about $180M guided)filed2026-11-12Q3 printed $161.3 million; with Q4 reiterated at approximately $180 million, H2 would be about $341 million versus H1's $254.9 million, about +34% (derived), with Q4 delivery still to come.sec.gov — Outcome of a signal this entry said to watch; recorded Nov 12 2026.
- Watched signal: Operating-margin trajectory (recovering off 25.5% or compressing further)filed2026-11-12Non-GAAP operating margin reached a record 29.5% in Q3 (27.0% in Q2); GAAP operating margin 24.7%.sec.gov — Outcome of a signal this entry said to watch; recorded Nov 12 2026.
- Watched signal: Whether HBM4 moves to hybrid bonding or stays on microbumpsfiled2026-11-12Management says hybrid-bonding activity remains at a low level, is not expected to be a substantial contributor in 2027, and should become meaningful from 2028; HBM inspection and 3D metrology matter more in 2027.marketbeat.com — Outcome of a signal this entry said to watch; recorded Nov 12 2026.
- Watched signal: China revenue share and any new export-control actionfiled2026-11-12China share was not disclosed; management says China remains strong and will be 'a meaningful part' of the 2027 backlog, and no new export-control action was mentioned.marketbeat.com — Outcome of a signal this entry said to watch; recorded Nov 12 2026.
The thesis on this name
State of the Memory Supercycle
The dominant HBM inspection name — estimated >40% share of HBM bump/pillar/TSV inspection, serving all three memory makers (ainvest/Kavout, 2025). Its Eagle/Emerald platforms do the 2D/3D inspection of micro-bumps, pillars and TSVs that every HBM stack requires, so content scales with HBM die-stack height (8-hi → 12-hi → 16-hi) and unit volume simultaneously — a double-lever. FY25 revenue ~$497M with double-digit FY26 growth guided and Q2'26 at $129–131M on strong HBM/OSAT backlog (PRNewswire, Q1'26). A pure-play on the HBM advanced-packaging layer specifically, mispriced relative to the mega-cap WFE names because the cyclicality scares generalists — but stack-height roadmap gives it secular content growth on top of the cycle.
State of the Memory Supercycle
The pure-play HBM advanced-packaging inspection toll-booth — TSV/hybrid-bonding/interposer inspection that gets MORE intensive at HBM4/HBM4e; the most HBM-levered small-cap, hence the most volatile.
State of the Memory Supercycle
Pure-play TSV/hybrid-bonding inspection; HBM4 is more metrology-intensive. High torque, small size; widen on >25% drawdowns.
Earnings, margins, COGS & capex
Camtek rode the AI/HBM packaging boom from $429M (FY24) to $496M (FY25, +16%), but Q1 FY26 was nearly flat YoY (+2.5%) as the HBM3E build-out paused ahead of the HBM4 transition. Management frames FY26 as H1-soft / H2-strong: it has booked $260M+ of HBM orders from two manufacturers for 2026–2027 and guides H2 FY26 revenue >25% above H1. Margins are healthy (~51% non-GAAP gross) but operating margin compressed ~600bps YoY on R&D/sales investment, and GAAP earnings were distorted by an ~$89M one-time loss on a 2025 convertible-note repurchase.
Income statement — where each revenue dollar goes
% of revenueOf every $1 of revenue, ~50¢ is cost of goods and ~30¢ operating expense, leaving ~20¢ of operating profit (~29¢ net).
Revenue trend
Margins
down slightly (was 52.1% Q1 FY25; ~51.6% FY25)
roughly flat (~50.5% FY25)
down (31.5% Q1 FY25; 30.0% FY25) on opex investment ahead of HBM4
down (32.6% Q1 FY25)
seasonally weak quarter; structurally strong FY
COGS structure
COGS is dominated by purchased materials and outsourced components — optics, cameras/sensors, precision stages, motion controllers, light sources, and computing/AI hardware — assembled in-house; plus manufacturing labor, system integration, warranty, and field-service cost. Gross margin sits ~50–52% because the value is in proprietary optics + image-processing/AI defect-classification software, not raw bill-of-materials; richer 3D-metrology and HBM-specific configurations carry above-average margin, while heavy China volume and competitive 2D-inspection deals pull mix the other way.
Capex
Low and discretionary — funds cleanroom/demo-lab capacity, R&D equipment for the HBM4/hybrid-bonding roadmap (Eagle, Hawk, Golden Eye, MicroProf), application labs near customers, and IT. No fab; Camtek is an asset-light tool integrator, so the bigger capital story is the ~$580M cash + securities war-chest funded by the 2030 converts, available for M&A/buybacks.
Latest earnings
Q2 FY2026 revenue of $133.2M beat the $129-131M guide, and non-GAAP operating margin recovered to 27.0% from 25.5% in Q1, while non-GAAP EPS of $0.78 was flat on $0.79 a year earlier (fact). Q3 is pre-announced slightly above its $158-160M guide, at $160-161M. On 10 Aug management guided H2 'more than 30%' above H1, and the Q3 and Q4 numbers now imply about +33% (est).
Q4 FY26 about $180M (+40% YoY); Q3 FY26 $160-161M pre-announced; FY2026 about $595M (about +20% on FY2025) (fact, 14 Oct 2026). On 10 Aug management guided H2 FY26 'more than 30%' above H1; the Q3 and Q4 numbers imply about +33% (est). Initial FY2027 outlook: revenue over $800M, more than 35% above 2026. Orders received since the start of 2026 exceed $800M (more than $600M at 10 Aug), with deliveries through 2026 and into 2027. Consensus as of July ($571.26M FY2026, $698.07M FY2027) sits below this guidance.
- Q1 FY26 revenue
- $121,659K (+2.5% YoY) - the flattest quarter since the AI ramp began
- Non-GAAP operating margin (Q1 FY26)
- 25.5%, from 31.5% a year earlier; GAAP 22.4% from 27.6%
- Opex growth vs revenue growth (Q1 FY26)
- +20.8% opex (R&D +38.2%) against +2.5% revenue
- FY2025 China revenue
- $243,935K = 49% of total (filed 20-F); Asia Pacific region ~91% of total
- FY2025 Korea revenue
- $36,888K, down 68% from $117,135K - from 27.3% of revenue to 7.4%
- FY2025 top customer
- 11% of total revenues (2024: 15%/10%/10%) - concentration is lower than the entry implied
- New orders announced 2 June 2026
- $105M+ ($55M tier-1 OSAT + $50M+ Hawk to an HBM maker), all for 2027 delivery
- Net cash / dilution
- ~$361.9M net cash; 0.00% 2030 converts add 5,123K diluted shares (~11% of basic)
Growth drivers
- HBM unit + capacity growth (SK Hynix ~50% share (Counterpoint, 2Q26), Micron, Samsung all expanding) and rising inspection/metrology steps per HBM stack
- HBM4/HBM4e transition — more die per stack (12-/16-Hi), tighter overlay, and eventual hybrid-bonding all add inspection/metrology insertions per wafer — content-per-stack tailwind
- AI advanced-packaging beyond HBM — CoWoS/interposers, chiplets, panel-level packaging, and 2.5D/3D logic driving OSAT + foundry tool demand
- New products Eagle and Hawk (3D metrology + 2D inspection for chiplets/HBM/hybrid bonding) expected to roughly double in revenue in FY26 (mgmt; fact)
- Installed-base service/spares/software annuity compounding as units ship
- Booked backlog: $260M+ of HBM orders for 2026–2027 from two manufacturers (mgmt; fact)
Bull & bear
The order book kept building while the multiple fell by about a third. Camtek has received more than $800M of orders since the start of 2026 (company, 14 Oct 2026; more than $600M at 10 Aug) and guides 2027 revenue above $800M, ~50% of revenue is AI-linked (filed), the balance sheet holds ~$362M of net cash funded by zero-coupon paper, and the stock now trades ~35x TTM non-GAAP, down from ~52x - with consensus targets sitting above spot rather than below it.
- The 2027 book is being built in public: $260M+ of HBM orders from two manufacturers for 2026-2027, plus an incremental $105M+ announced 2 June 2026 - $55M from a tier-1 OSAT and $50M+ of Hawk systems from a leading HBM player, all for 2027 delivery (filed 6-K). That June announcement is the first hard dollar validation of the Hawk platform the bull case rests on
- Content-per-stack, not just unit volume: inspection and metrology insertions rise with each HBM generation (12-/16-Hi, HBM4/4e, and eventually hybrid bonding), so Camtek can grow served steps even on flat HBM units. SK Hynix's reported ~$31B capex plan is the spend behind that
- Margins compressed by choice, not by price: the Q1 squeeze is opex-driven (R&D +38.2% YoY) against flat revenue, with gross margin down only ~90-110bps. If the guided H2 volume arrives, the operating leverage reverses mechanically
- Genuinely asset-light and unlevered: $22.5M of FY2025 capex (4.5% of revenue), $141.9M of FY2025 operating cash flow, ~$362M net cash and 0.00%-coupon converts due 2030 - the war chest costs nothing to carry and funds M&A on the company's own timetable
- Less customer-concentrated than the story suggests: the largest FY2025 customer was 11% of revenue, down from 15% in 2024, across an installed base of over 3,000 systems (filed 20-F). Buyer pricing leverage is a weaker argument than the concentration story suggests
- Valuation reset with no reported deterioration: ~$112 vs ~$154-168 in late June, ~35x TTM non-GAAP against ~52x, and a consensus target range of $126-$200 that now sits entirely ABOVE spot
- Orders received since the start of 2026 passed $600M by 10 Aug 2026 and $800M by 14 Oct 2026, and the first 2027 outlook is revenue above $800M, more than 35% above 2026 (company, 6-K). The company's updated target model, a goal rather than guidance, replaces its earlier $750M model with about $1.2B of organic annual revenue in about three years (company presentation, 14 Oct 2026)
The claim the whole entry rests on, H2 more than 25% above H1, now has company figures behind it (Q2 $133.2M above its guide, Q3 $160-161M pre-announced, Q4 about $180M guided, about +33% H2 over H1, est), so the open risks are delivery of Q4, dependence on the HBM makers' ramp timing, and a 2027 digestion year. Underneath it, the filings show FY2025's growth came from China (+84%) while Korea collapsed 68%, so the 'HBM toll-booth' framing and the 49% China export-control exposure are the same risk wearing two labels.
- The filed geography does not match the narrative: FY2025 growth was China +$111.4M (+84%) and Asia Pacific +$35.2M against Korea -$80.2M (-68%, from 27.3% of revenue to 7.4%). Attribution is by shipment destination so HBM tools can land outside Korea - but you cannot look at this table and cleanly separate 'AI/HBM toll-booth' revenue from 'China' revenue, and 49% of the company is China
- SK Hynix reported slower-than-expected HBM4 shipment ramps pushing revenue into H2 2026. Camtek's Q3 pre-announcement and Q4 guide have since put H2 about 33% above H1 (Q3 $160-161M, Q4 about $180M; est), so Q4 delivery depends on those same tools landing on schedule; a quarter of slippage would move part of the step-up into 2027
- Q1 was the warning shot and Q2 answered part of it: Q1 showed +2.5% revenue growth, non-GAAP operating margin down about 600bps to 25.5%, operating income down 17% and operating cash flow of $3.1M against a $40.9M receivables build. Q2 revenue was a record $133.2M and non-GAAP operating margin recovered to 27.0%, but operating cash flow was only $12.2M and non-GAAP EPS of $0.78 was flat on a year earlier ($0.79)
- Sector de-rating on AI-capex sustainability, not on Camtek: over $1 trillion of semiconductor and AI-hardware market cap erased between 24 and 29 July, with CAMT down 7.5% and 9.4% on consecutive sessions. If the market is right that AI infrastructure spend is peaking, the most HBM-levered small-cap in the equipment group is the wrong place to be
- Export-control exposure is unchanged and unhedged: 49% of FY2025 revenue shipped to China and ~91% to Asia Pacific (filed 20-F). One rule change is a step-down in half the business, and there is no geographic diversification in the FY2025 numbers to cushion it
- Quiet dilution and a standing supply path: the 0.00% converts add 5,123K shares to the diluted count (~11% of basic), and in June the registration-rights agreement with Priortech and Chroma ATE was extended to 2031 with the demand threshold cut to 1% of share capital. Neither is urgent
- Competitive overhang is unresolved: KLA, Applied Materials, Onto Innovation and Nova are all larger and all pushing into advanced-packaging inspection and metrology, and if HBM4 stays on microbumps the hybrid-bonding content step-up slips right
What it is worth
Peer-relative multiple (non-GAAP forward P/E vs Onto/KLA/Nova) cross-checked with a reverse-DCF sanity test on the implied HBM-content growth.
~$110–$130
HBM digestion / margin compression persists, multiple de-rates toward ~30–35x on flat-to-low-teens growth — the $112.37 3 Nov 2026 close sits inside this range (~31x FY2026 consensus EPS of $3.63; estimate, aggregator).
~$165–$185
H2 FY26 delivers >25% H1 and the HBM4 order book converts; ~45–50x on re-accelerating mid-teens-plus growth (near consensus).
~$220–$260
HBM4/hybrid-bonding content step-up plus Eagle/Hawk ramp drive 25%+ growth and margin recovery, sustaining a ~55–60x premium.
At $112.37 (3 Nov 2026 close) the stock trades ~35x non-GAAP TTM EPS (~$3.17 to 30 Jun 2026) — a premium to the broad equipment group that requires HBM4 to re-accelerate growth back to the 20%+ range; the GAAP ~152x P/E is distorted by the one-time $89M convert-repurchase loss and should be ignored. Consensus 12-mo target ~$170 (range $126–$200; estimate, aggregator) sits above spot.
SWOT
Strengths
- Leading share in HBM/advanced-packaging optical inspection and 3D metrology — serves all three memory makers (SK Hynix, Micron, Samsung); estimated >40% HBM-inspection share (estimate)
- High, stable margins (~51% non-GAAP gross, ~30% FY op margin) for a hardware OEM, anchored by proprietary optics + AI defect-classification software
- Fortress balance sheet — ~$850M liquid assets, net cash ~$362M, funded cheaply by 0.00% converts due 2030 — optionality for M&A/buybacks
- Content-per-wafer tailwind — each HBM generation (12-/16-Hi, HBM4/4e, hybrid bonding) adds inspection/metrology insertions, structurally growing its served steps
- Fresh, well-received product cycle (Eagle, Hawk, Golden Eye, MicroProf) extending it into chiplets and hybrid bonding
Weaknesses
- Extreme HBM/memory-capex concentration — revenue tracks a single, notoriously cyclical end-market; a customer capex pause hits hard (Q1 FY26 +2.5% is the warning shot)
- ~49% of FY25 sales from China (fact) — heavy export-control and demand-policy exposure
- Customer concentration in a handful of memory makers + leading OSATs/foundries gives buyers pricing leverage
- Lumpy, order-driven revenue and back-half-loaded years make quarterly results volatile and hard to model
- Small-cap scale vs KLA/Applied/Onto — less R&D and balance-sheet firepower if a large incumbent pushes into HBM inspection/metrology
Opportunities
- HBM4/HBM4e ramp (2026–2027) and the eventual move to hybrid bonding — Camtek's highest content-per-stack inflection
- Expansion in CoWoS/interposer, chiplet, and panel-level packaging as AI packaging diversifies beyond HBM
- Deepening the software/AI defect-classification and metrology annuity to lift recurring revenue and margin
- M&A with the converts war-chest to add metrology adjacencies and reduce single-market dependence
- Share gains at OSATs (ASE, Amkor) and foundries as advanced packaging migrates from memory to logic
Threats
- HBM digestion/overbuild or an AI-capex pullback that delays memory-maker tool orders
- HBM4 staying on microbumps longer than expected — delays the hybrid-bonding content upgrade thesis
- KLA, Applied Materials, Onto Innovation, or Nova pushing harder into advanced-packaging inspection/metrology
- US/Netherlands export controls tightening on China shipments — a direct hit to ~49% of sales
- Memory-maker in-housing of inspection steps or pricing pressure from concentrated buyers
Moats, dependencies & bottlenecks
Moats
Proprietary optics + AI defect-classification software validated on live HBM lines High while it stays a generation ahead; erodes if an incumbent matches detection on HBM4/hybrid-bonding defects Detecting buried copper-to-copper voids and sub-micron overlay is the hard part; recipes are co-developed and tuned per customer line.
Qualification lock-in / switching cost at memory makers and OSATs re-qualifying inspection on a running yield-critical line is slow and risky, so incumbents stay Once a tool is in the process flow gating yield, swapping it risks the ramp; this is the stickiest part of the franchise.
grows with units but is a smaller share than hardware A compounding recurring tail that cushions hardware lumpiness.
KLA/Applied/Onto dwarf Camtek on R&D and balance sheet Camtek wins on focus and HBM-specific application depth, not scale; this is the soft flank.
High through the HBM4/4e/hybrid-bonding roadmap More inspection insertions per generation is a moat-adjacent growth engine, not a defensive barrier.
Dependencies
The dominant demand driver; a capex pause or HBM overbuild directly throttles orders — visible in Q1 FY26's flat YoY.
Concentrated geographic exposure subject to US/allied export controls and China demand policy.
Camtek is a derivative of the AI-compute capex cycle; an AI-spend slowdown flows straight through.
sensors/cameras, precision stages, compute components from suppliers Specialized optical and motion components; supply tightness or pricing hits COGS and lead times.
HBM4 adopting hybrid bonding / higher metrology intensity on schedule The content-upgrade thesis depends on the roadmap; HBM4 staying on microbumps longer delays the step-up.
Advantages
- Purest public-equity exposure to HBM/advanced-packaging inspection — no diluting legacy segments
- Design-ins at all three memory makers plus leading OSATs/foundries
- Software/AI defect-classification depth tuned on live HBM yield lines
- Net-cash fortress (~$362M) funded by 0.00% converts — cheap optionality for M&A/buybacks
- High, resilient margins (~51% non-GAAP gross) for a hardware OEM
- Fresh, adopted product cycle (Eagle, Hawk) extending into chiplets and hybrid bonding
Weaknesses
- Single-end-market (memory/HBM) concentration amplifies cyclicality
- ~49% China revenue exposure (fact) — high regulatory tail risk
- Operating-margin compression in H1 FY26 (non-GAAP op margin 31.5%→25.5% YoY)
- Lumpy, back-half-loaded revenue is volatile and hard to forecast quarter to quarter
- Small-cap scale vs KLA/Applied/Onto on R&D and balance sheet
- Premium valuation leaves no margin for an HBM digestion miss
Bottlenecks
- Customer order timing — back-half-loaded years and lumpy HBM capex make near-term revenue hostage to a few buyers' ramp schedules
- Pace of the HBM4/hybrid-bonding transition — the content-per-stack upgrade only pays off when customers actually move the process
- Export-control regime on China shipments — a policy change can gate ~half of revenue overnight
- R&D/scale ceiling vs KLA/Applied/Onto — staying a generation ahead on defect detection with a fraction of their budgets
- Specialized optical-component and skilled-integration supply for ramping system output
Top signals & trends
Top signals
7 sourced items since this entry's vintage are in the evidence rows (latest print, guidance, deals, resolved watch items); the analysis text is as of the entry's stated date and predates them unless dated otherwise.
$260M+ already booked for 2026–2027; pace of follow-on orders confirms or breaks the H2 re-accel.
Q2 beat its guide and the Q3 pre-announcement and Q4 guide put H2 about 33% above H1 (est), so the 'soft H1 is digestion' reading is holding; what remains is delivery of Q4 at about $180M and of the 2027 outlook of more than $800M.
Opex outran flat revenue in Q1 FY26; watch whether the H2 volume restores leverage.
~49% of sales; a tightening headline is the single biggest downside catalyst.
Validates the chiplet/hybrid-bonding expansion beyond core HBM 2D inspection.
Hybrid bonding is the content-intensity upgrade; a delay pushes the step-up into 2027+.
Trends
Primary structural tailwind; SK Hynix ~50% of HBM revenue (Counterpoint, 2Q26), Micron/Samsung expanding.
More insertions per stack = content growth independent of unit volume — the core toll-booth thesis.
Buried copper-void/overlay inspection is harder and higher-value; timing is the variable.
Diversifies demand beyond HBM toward OSATs and foundries over time.
Direct risk to ~49% of FY25 sales; a structural overhang.
The same lever that drove +36% FY24 can flatten growth fast, as Q1 FY26 (+2.5%) showed.
Ecosystem & competitor graph
Suppliers feed the company; customers pull from it. Line thickness shows the strength of each tie (supply-chain dependency, customer earnings contribution). Hover to isolate a tie.
Optical-component & precision-lens makers (e.g. ZEISS, Edmund Optics) High-resolution optics are the core of the inspection/metrology head.
Sony, Teledyne) High-speed line/area sensors that capture defect images at throughput.
Precision motion / stage & controller vendors Sub-micron wafer-handling stages and motion controllers for scan accuracy.
NVIDIA, Intel, AMD/Xilinx) AI/compute hardware runs the real-time defect-classification pipeline inside the tools.
Contract manufacturers / machined-part & subassembly suppliers Outsourced fabrication of mechanical subassemblies that Camtek integrates in-house.
HBM leader (~50% share, Counterpoint 2Q26); largest HBM inspection/metrology customer base.
US memory maker scaling HBM3E/HBM4 — a core HBM customer.
Memory + foundry; HBM and advanced-packaging tool buyer.
CoWoS/advanced-packaging foundry — interposer/2.5D inspection demand.
Largest OSAT — bumping, packaging, and test inspection insertions.
#2 OSAT; advanced-packaging and chiplet inspection customer.
Closest US-listed peer — advanced-packaging metrology/inspection (Dragonfly), also HBM/AI-packaging levered; the most direct head-to-head.
Inspection/metrology giant (~25% overall share); dominant in front-end, increasingly active in advanced packaging — the scale threat.
Broad equipment leader with packaging and metrology (incl. eBeam) initiatives; vast R&D and balance sheet.
Israeli metrology peer (dimensional/materials/chemical); adjacent rather than direct in HBM optical inspection but overlapping in advanced-packaging metrology.
Inspection specialist (mask/EUV-adjacent); a niche competitor in select inspection segments.
Japanese inspection/metrology suppliers competing in specific packaging and process-control niches.